Caricamento...
Triple versus LAMA/LABA combination therapy for patients with COPD: a systematic review and meta-analysis
BACKGROUND: Recently, the addition of inhaled corticosteroid (ICS) to long-acting muscarinic antagonist (LAMA) and long-acting beta-agonist (LABA) combination therapy has been recommended for patients with COPD who have severe symptoms and a history of exacerbations because it reduces the exacerbati...
Salvato in:
| Pubblicato in: | Respir Res |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8218448/ https://ncbi.nlm.nih.gov/pubmed/34154582 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-021-01777-x |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|